Skip to main content
SpringerLink
Log in

Peritoneal Carcinomatosis: A Final Frontier

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Pilati P, Mocellin S, Rossi C, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003; 10: 508–13.

    Article  PubMed  Google Scholar 

  2. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies, results of the EVOCAPE 1 Multicenter Prospective Study. Cancer 2000; 88: 358–63.

    Google Scholar 

  3. Sugarbaker P. Peritoneal Carcinomatosis: Drugs and Diseases. Boston: Kluwer, 1996.

    Google Scholar 

  4. Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71–6.

    Article  CAS  PubMed  Google Scholar 

  5. Witkamp AJ, deBree E, Kaag MM, et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001; 37: 979–84.

    Google Scholar 

  6. McQuellon RP, Logie BW, Lehman AB, et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2003; 10: 155–62.

    Article  PubMed  Google Scholar 

  7. McCarter M, Fong Y. Role for cytoreduction in multimodality treatments for cancer. Ann Surg Oncol 2001; 8: 38–43.

    Google Scholar 

  8. Morton D, Ollila D, Hsueh E, et al. Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma. Ca Cancer J Clin 1999; 49: 101–16.

    Google Scholar 

  9. Zoetmulder F, Verwaal V, Ruth S. Hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin-C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin. Abstract presented at: Proceedings of American Society of Clinical Oncology; May 2002; Orlando, FL.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota

    Robert P. Sticca MD, FACS

  2. Department of Surgery, University of North Dakota School of Medicine and Health Sciences, 501 North Columbia Rd., Grand Forks, ND, 58203

    Robert P. Sticca MD, FACS

Authors
  1. Robert P. Sticca MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert P. Sticca MD, FACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sticca, R.P. Peritoneal Carcinomatosis: A Final Frontier. Ann Surg Oncol 10, 484–485 (2003). https://doi.org/10.1245/ASO.2003.04.907

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.04.907

Search

Navigation